Thomas Eschenhagen Institute of Experimental Pharmacology and Toxicology University Medical Center Hamburg-Eppendorf Biography Publications Institution JoVE Articles Thomas Eschenhagen has not added a biography. If you are Thomas Eschenhagen and would like to personalize this page please email our Author Liaison for assistance. Publications Toward Standardization of Echocardiography for the Evaluation of Left Ventricular Function in Adult Rodents: a Position Paper of the ESC Working Group on Myocardial Function Cardiovascular Research. May, 2020 | Pubmed ID: 32365197 Aging-regulated Anti-apoptotic Long Non-coding RNA Sarrah Augments Recovery from Acute Myocardial Infarction Nature Communications. Apr, 2020 | Pubmed ID: 32341350 An Epidemiological Study Exploring a Possible Impact of Treatment with ACE Inhibitors or Angiotensin Receptor Blockers on ACE2 Plasma Concentrations Journal of Molecular and Cellular Cardiology. Apr, 2020 | Pubmed ID: 32268149 Regulation of I and Force by PDEs in Human-induced Pluripotent Stem Cell-derived Cardiomyocytes British Journal of Pharmacology. Feb, 2020 | Pubmed ID: 32092149 Case Report On: Very Early Afterdepolarizations in HiPSC-Cardiomyocytes-An Artifact by Big Conductance Calcium Activated Potassium Current (I) Cells. Jan, 2020 | Pubmed ID: 31968557 Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency Stem Cell Reports. Feb, 2020 | Pubmed ID: 31956082 Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive? Annual Review of Pharmacology and Toxicology. 01, 2020 | Pubmed ID: 31506008 Human Pluripotent Stem Cell-derived Cardiomyocytes for Studying Energy Metabolism Biochimica Et Biophysica Acta. Molecular Cell Research. Mar, 2020 | Pubmed ID: 30954570 Phosphomimetic Cardiac Myosin-binding Protein C Partially Rescues a Cardiomyopathy Phenotype in Murine Engineered Heart Tissue Scientific Reports. Dec, 2019 | Pubmed ID: 31796859 Disease Modeling of a Mutation in α-actinin 2 Guides Clinical Therapy in Hypertrophic Cardiomyopathy EMBO Molecular Medicine. 12, 2019 | Pubmed ID: 31680489 A Magnetics-based Approach for Fine-tuning Afterload in Engineered Heart Tissues ACS Biomaterials Science & Engineering. Jul, 2019 | Pubmed ID: 31637285 Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis Molecular Therapy. Nucleic Acids. Dec, 2019 | Pubmed ID: 31634682 Chronic Intermittent Tachypacing by an Optogenetic Approach Induces Arrhythmia Vulnerability in Human Engineered Heart Tissue Cardiovascular Research. Oct, 2019 | Pubmed ID: 31598634 Simultaneous Measurement of Excitation-contraction Coupling Parameters Identifies Mechanisms Underlying Contractile Responses of HiPSC-derived Cardiomyocytes Nature Communications. 09, 2019 | Pubmed ID: 31541103 Blockade of MiR-140-3p Prevents Functional Deterioration in Afterload-enhanced Engineered Heart Tissue Scientific Reports. 08, 2019 | Pubmed ID: 31391475 Author Correction: Differentiation of Cardiomyocytes and Generation of Human Engineered Heart Tissue Nature Protocols. Sep, 2019 | Pubmed ID: 31384055 Human IPS Cell-derived Engineered Heart Tissue Does Not Affect Ventricular Arrhythmias in a Guinea Pig Cryo-injury Model Scientific Reports. 07, 2019 | Pubmed ID: 31285568 Analysis of Fibrosis in Control or Pressure Overloaded Rat Hearts After Mechanical Unloading by Heterotopic Heart Transplantation Scientific Reports. 04, 2019 | Pubmed ID: 30952943 Dissecting HiPSC-CM Pacemaker Function in a Cardiac Organoid Model Biomaterials. Jun, 2019 | Pubmed ID: 30933775 Heart Repair With Myocytes Circulation Research. 03, 2019 | Pubmed ID: 30870126 Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors ChemMedChem. 04, 2019 | Pubmed ID: 30768867 ESC Working Group on Cellular Biology of the Heart: Position Paper for Cardiovascular Research: Tissue Engineering Strategies Combined with Cell Therapies for Cardiac Repair in Ischaemic Heart Disease and Heart Failure Cardiovascular Research. 03, 2019 | Pubmed ID: 30657875 Mechanistic Role of the CREB-regulated Transcription Coactivator 1 in Cardiac Hypertrophy Journal of Molecular and Cellular Cardiology. Feb, 2019 | Pubmed ID: 30521840 Piezo-bending Actuators for Isometric or Auxotonic Contraction Analysis of Engineered Heart Tissue Journal of Tissue Engineering and Regenerative Medicine. 01, 2019 | Pubmed ID: 30334614 Treatments Targeting Inotropy European Heart Journal. Nov, 2019 | Pubmed ID: 30295807 Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium Stem Cell Reports. Dec, 2018 | Pubmed ID: 30416051 Normalization of Force to Muscle Cross-sectional Area: A Helpful Attempt to Reduce Data Scattering in Contractility Studies? Acta Physiologica (Oxford, England). 12, 2018 | Pubmed ID: 30338659 Cardiomyopathy Phenotypes in Human-induced Pluripotent Stem Cell-derived Cardiomyocytes-a Systematic Review Pflugers Archiv : European Journal of Physiology. Oct, 2018 | Pubmed ID: 30324321 Satellite Cells Delivered in Their Niche Efficiently Generate Functional Myotubes in Three-dimensional Cell Culture PloS One. 2018 | Pubmed ID: 30222770 Rat Atrial Engineered Heart Tissue: a New in Vitro Model to Study Atrial Biology Basic Research in Cardiology. 09, 2018 | Pubmed ID: 30178427 From Basic Science to High Performance Medicine European Heart Journal. Aug, 2018 | Pubmed ID: 30165623 Exaggerated Cardiotoxicity of Sunitinib in Stressed 3-Dimensional Heart Muscles JACC. Basic to Translational Science. Apr, 2018 | Pubmed ID: 30062213 Clonal Dynamics Studied in Cultured Induced Pluripotent Stem Cells Reveal Major Growth Imbalances Within a Few Weeks Stem Cell Research & Therapy. 06, 2018 | Pubmed ID: 29914569 No Effect of Thymosin Beta-4 on the Expression of the Transcription Factor Islet-1 in the Adult Murine Heart Pharmacology Research & Perspectives. 06, 2018 | Pubmed ID: 29864245 Pharmacological Inhibition of DNA Methylation Attenuates Pressure Overload-induced Cardiac Hypertrophy in Rats Journal of Molecular and Cellular Cardiology. Jul, 2018 | Pubmed ID: 29792884 CRISPR/Cas9 Editing in Human Pluripotent Stem Cell-cardiomyocytes Highlights Arrhythmias, Hypocontractility, and Energy Depletion As Potential Therapeutic Targets for Hypertrophic Cardiomyopathy European Heart Journal. 11, 2018 | Pubmed ID: 29741611 Three-Dimensional Human IPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering Cell Reports. Apr, 2018 | Pubmed ID: 29669293 A New Concept of Fibroblast Dynamics in Post-myocardial Infarction Remodeling The Journal of Clinical Investigation. 05, 2018 | Pubmed ID: 29664015 [Cardiology 2018 : From Basic Science to High Efficiency Medicine] Herz. Mar, 2018 | Pubmed ID: 29516153 Contractile Work Contributes to Maturation of Energy Metabolism in HiPSC-Derived Cardiomyocytes Stem Cell Reports. 03, 2018 | Pubmed ID: 29503093 Low Resting Membrane Potential and Low Inward Rectifier Potassium Currents Are Not Inherent Features of HiPSC-Derived Cardiomyocytes Stem Cell Reports. 03, 2018 | Pubmed ID: 29429959 MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo Circulation Research. Feb, 2018 | Pubmed ID: 29282212 Cardiovascular Research in Germany Circulation Research. 08, 2017 | Pubmed ID: 28819038 Prominent Differences in Left Ventricular Performance and Myocardial Properties Between Right Ventricular and Left Ventricular-based Pacing Modes in Rats Scientific Reports. 07, 2017 | Pubmed ID: 28725029 Human IPSC-derived Cardiomyocytes Cultured in 3D Engineered Heart Tissue Show Physiological Upstroke Velocity and Sodium Current Density Scientific Reports. Jul, 2017 | Pubmed ID: 28710467 Cardiomyocyte Regeneration: A Consensus Statement Circulation. 08, 2017 | Pubmed ID: 28684531 Evaluation of MYBPC3 Trans-Splicing and Gene Replacement As Therapeutic Options in Human IPSC-Derived Cardiomyocytes Molecular Therapy. Nucleic Acids. Jun, 2017 | Pubmed ID: 28624223 Differentiation of Cardiomyocytes and Generation of Human Engineered Heart Tissue Nature Protocols. Jun, 2017 | Pubmed ID: 28492526 Blinded Contractility Analysis in HiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae Toxicological Sciences : an Official Journal of the Society of Toxicology. 07, 2017 | Pubmed ID: 28453742 Engineering Cardiac Muscle Tissue: A Maturating Field of Research Circulation Research. Apr, 2017 | Pubmed ID: 28450366 Thymosin β4 Improves Differentiation and Vascularization of EHTs Stem Cells International. 2017 | Pubmed ID: 28191018 Diltiazem Prevents Stress-induced Contractile Deficits in Cardiomyocytes, but Does Not Reverse the Cardiomyopathy Phenotype in Mybpc3-knock-in Mice The Journal of Physiology. Jan, 2017 | Pubmed ID: 28090637 Epigallocatechin-3-Gallate Accelerates Relaxation and Ca(2+) Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice Frontiers in Physiology. 2016 | Pubmed ID: 27994558 Towards a Tissue-Engineered Contractile Fontan-Conduit: The Fate of Cardiac Myocytes in the Subpulmonary Circulation PloS One. 2016 | Pubmed ID: 27875570 Cardiac Repair in Guinea Pigs with Human Engineered Heart Tissue from Induced Pluripotent Stem Cells Science Translational Medicine. Nov, 2016 | Pubmed ID: 27807283 Ca(2+)-Currents in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Effects of Two Different Culture Conditions Frontiers in Pharmacology. 2016 | Pubmed ID: 27672365 Is Stimulation of Cardiomyocyte Renewal a Facette of Reversible Catecholamine Toxicity? Circulation Research. Sep, 2016 | Pubmed ID: 27635079 Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes Against Ischemia/Reperfusion Injury Oxidative Medicine and Cellular Longevity. 2016 | Pubmed ID: 27403231 Block of Na(+)/Ca(2+) Exchanger by SEA0400 in Human Right Atrial Preparations from Patients in Sinus Rhythm and in Atrial Fibrillation European Journal of Pharmacology. Oct, 2016 | Pubmed ID: 27373849 Outcomes of Patients in Long-Term Opioid Maintenance Treatment Substance Use & Misuse. Sep, 2016 | Pubmed ID: 27355105 Human Engineered Heart Tissue: Analysis of Contractile Force Stem Cell Reports. Jul, 2016 | Pubmed ID: 27211213 Comparison of the Effects of a Truncating and a Missense MYBPC3 Mutation on Contractile Parameters of Engineered Heart Tissue Journal of Molecular and Cellular Cardiology. Aug, 2016 | Pubmed ID: 27108529 Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: Cell-based Therapies for Myocardial Repair and Regeneration in Ischemic Heart Disease and Heart Failure European Heart Journal. Apr, 2016 | Pubmed ID: 27055812 Ataxin-10 is Part of a Cachexokine Cocktail Triggering Cardiac Metabolic Dysfunction in Cancer Cachexia Molecular Metabolism. Feb, 2016 | Pubmed ID: 26909315 Myocardial Tissue Engineering for Cardiac Repair The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. Mar, 2016 | Pubmed ID: 26856673 A New Animal Model for Investigation of Mechanical Unloading in Hypertrophic and Failing Hearts: Combination of Transverse Aortic Constriction and Heterotopic Heart Transplantation PloS One. 2016 | Pubmed ID: 26841021 Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue PloS One. 2016 | Pubmed ID: 26840448 S-glutathiolation Impairs Phosphoregulation and Function of Cardiac Myosin-binding Protein C in Human Heart Failure FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. May, 2016 | Pubmed ID: 26839380 Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue Tissue Engineering. Part A. Feb, 2016 | Pubmed ID: 26763667 DNA Methylation in an Engineered Heart Tissue Model of Cardiac Hypertrophy: Common Signatures and Effects of DNA Methylation Inhibitors Basic Research in Cardiology. Jan, 2016 | Pubmed ID: 26680771 Knock-out of Nexilin in Mice Leads to Dilated Cardiomyopathy and Endomyocardial Fibroelastosis Basic Research in Cardiology. Jan, 2016 | Pubmed ID: 26659360 Heart Regeneration Biochimica Et Biophysica Acta. Jul, 2016 | Pubmed ID: 26597703 General Practitioners' Adherence to Chronic Heart Failure Guidelines Regarding Medication: the GP-HF Study Clinical Research in Cardiology : Official Journal of the German Cardiac Society. May, 2016 | Pubmed ID: 26552905 Ranolazine Antagonizes Catecholamine-induced Dysfunction in Isolated Cardiomyocytes, but Lacks Long-term Therapeutic Effects in Vivo in a Mouse Model of Hypertrophic Cardiomyopathy Cardiovascular Research. Jan, 2016 | Pubmed ID: 26531128 Pharmacokinetics of the Experimental Non-Nucleosidic DNA Methyl Transferase Inhibitor N-Phthalyl-L-Tryptophan (RG 108) in Rats Basic & Clinical Pharmacology & Toxicology. May, 2016 | Pubmed ID: 26525153 Human Engineered Heart Tissue As a Model System for Drug Testing Advanced Drug Delivery Reviews. Jan, 2016 | Pubmed ID: 26026976 I-1-deficiency Negatively Impacts Survival in a Cardiomyopathy Mouse Model International Journal of Cardiology. Heart & Vasculature. Sep, 2015 | Pubmed ID: 28785686 β 1 Adrenoceptor Antagonistic Effects of the Supposedly Selective β 2 Adrenoceptor Antagonist ICI 118,551 on the Positive Inotropic Effect of Adrenaline in Murine Hearts Pharmacology Research & Perspectives. Oct, 2015 | Pubmed ID: 26516580 Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization Journal of the American College of Cardiology. Nov, 2015 | Pubmed ID: 26516004 The E3 Ubiquitin Ligase Asb2β is Downregulated in a Mouse Model of Hypertrophic Cardiomyopathy and Targets Desmin for Proteasomal Degradation Journal of Molecular and Cellular Cardiology. Oct, 2015 | Pubmed ID: 26343497 Immunobiology of Fibrin-based Engineered Heart Tissue Stem Cells Translational Medicine. Jun, 2015 | Pubmed ID: 25947338 LQT1-phenotypes in HiPSC: Are We Measuring the Right Thing? Proceedings of the National Academy of Sciences of the United States of America. Apr, 2015 | Pubmed ID: 25795242 Prolonged Action Potentials in HCM-derived IPSC--biology or Artefact? Cardiovascular Research. Apr, 2015 | Pubmed ID: 25691543 Deciphering the MicroRNA Signature of Pathological Cardiac Hypertrophy by Engineered Heart Tissue- and Sequencing-technology Journal of Molecular and Cellular Cardiology. Apr, 2015 | Pubmed ID: 25633833 Modelling Sarcomeric Cardiomyopathies in the Dish: from Human Heart Samples to IPSC Cardiomyocytes Cardiovascular Research. Apr, 2015 | Pubmed ID: 25618410 Assessment of DNA Synthesis in Islet-1⁺ Cells in the Adult Murine Heart Biochemical and Biophysical Research Communications. Jan, 2015 | Pubmed ID: 25450620 Development of Phosphatase Inhibitor-1 Peptides Acting As Indirect Activators of Phosphatase 1 Naunyn-Schmiedeberg's Archives of Pharmacology. Mar, 2015 | Pubmed ID: 25416155 Mybpc3 Gene Therapy for Neonatal Cardiomyopathy Enables Long-term Disease Prevention in Mice Nature Communications. Dec, 2014 | Pubmed ID: 25463264 FHL2 Expression and Variants in Hypertrophic Cardiomyopathy Basic Research in Cardiology. 2014 | Pubmed ID: 25358972 Effects of Proarrhythmic Drugs on Relaxation Time and Beating Pattern in Rat Engineered Heart Tissue Basic Research in Cardiology. 2014 | Pubmed ID: 25209140 The Continuum of Personalized Cardiovascular Medicine: a Position Paper of the European Society of Cardiology European Heart Journal. Dec, 2014 | Pubmed ID: 25148837 Cardiac Arrhythmia Induced by Genetic Silencing of 'funny' (f) Channels is Rescued by GIRK4 Inactivation Nature Communications. Aug, 2014 | Pubmed ID: 25144323 Generation of Strip-format Fibrin-based Engineered Heart Tissue (EHT) Methods in Molecular Biology (Clifton, N.J.). 2014 | Pubmed ID: 25070332 Prostaglandin E2 Does Not Attenuate Adrenergic-induced Cardiac Contractile Response Naunyn-Schmiedeberg's Archives of Pharmacology. Oct, 2014 | Pubmed ID: 24974239 Guanabenz Interferes with ER Stress and Exerts Protective Effects in Cardiac Myocytes PloS One. 2014 | Pubmed ID: 24892553 Functional Improvement and Maturation of Rat and Human Engineered Heart Tissue by Chronic Electrical Stimulation Journal of Molecular and Cellular Cardiology. Sep, 2014 | Pubmed ID: 24852842 Dichloroacetate Prevents Restenosis in Preclinical Animal Models of Vessel Injury Nature. Apr, 2014 | Pubmed ID: 24747400 Myocardial Tissue Engineering: in Vitro Models Cold Spring Harbor Perspectives in Medicine. Mar, 2014 | Pubmed ID: 24591534 Automated Analysis of Contractile Force and Ca2+ Transients in Engineered Heart Tissue American Journal of Physiology. Heart and Circulatory Physiology. May, 2014 | Pubmed ID: 24585781 Cardiac Tissue Engineering: State of the Art Circulation Research. Jan, 2014 | Pubmed ID: 24436431 Paradoxical Effects on Force Generation After Efficient β1-adrenoceptor Knockdown in Reconstituted Heart Tissue The Journal of Pharmacology and Experimental Therapeutics. Apr, 2014 | Pubmed ID: 24431469 In Vitro Perfusion of Engineered Heart Tissue Through Endothelialized Channels Tissue Engineering. Part A. Feb, 2014 | Pubmed ID: 24156346 Melusin Protects from Cardiac Rupture and Improves Functional Remodelling After Myocardial Infarction Cardiovascular Research. Jan, 2014 | Pubmed ID: 24130190 Functional MicroRNA Library Screening Identifies the Hypoxamir MiR-24 As a Potent Regulator of Smooth Muscle Cell Proliferation and Vascularization Antioxidants & Redox Signaling. Sep, 2014 | Pubmed ID: 24063572 [Interview by Anne-Katrin Döbler] Deutsche Medizinische Wochenschrift (1946). Nov, 2013 | Pubmed ID: 24350367 B-scan Ultrasonographic Monitoring of Orthotopic Xenografted Plexiform Neurofibroma in Mice In Vivo (Athens, Greece). Nov-Dec, 2013 | Pubmed ID: 24292574 Nfat and MiR-25 Cooperate to Reactivate the Transcription Factor Hand2 in Heart Failure Nature Cell Biology. Nov, 2013 | Pubmed ID: 24161931 Contractile Abnormalities and Altered Drug Response in Engineered Heart Tissue from Mybpc3-targeted Knock-in Mice Journal of Molecular and Cellular Cardiology. Oct, 2013 | Pubmed ID: 23896226 Repair of Mybpc3 MRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy Molecular Therapy. Nucleic Acids. Jul, 2013 | Pubmed ID: 23820890 Phosphodiesterase-2 is Upregulated in Human Failing Hearts and Blunts β-Adrenergic Responses in Cardiomyocytes Journal of the American College of Cardiology. Jun, 2013 | Pubmed ID: 23810893 Rescue of Cardiomyopathy Through U7snRNA-mediated Exon Skipping in Mybpc3-targeted Knock-in Mice EMBO Molecular Medicine. Jul, 2013 | Pubmed ID: 23716398 Development of a Colorimetric and a Fluorescence Phosphatase-inhibitor Assay Suitable for Drug Discovery Approaches Journal of Biomolecular Screening. Sep, 2013 | Pubmed ID: 23606651 Heterozygous LmnadelK32 Mice Develop Dilated Cardiomyopathy Through a Combined Pathomechanism of Haploinsufficiency and Peptide Toxicity Human Molecular Genetics. Aug, 2013 | Pubmed ID: 23575224 Impact of ANKRD1 Mutations Associated with Hypertrophic Cardiomyopathy on Contraction Parameters of Engineered Heart Tissue Basic Research in Cardiology. May, 2013 | Pubmed ID: 23572067 Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Calcium Signaling and Arrhythmias in the Heart Evoked by β-adrenergic Stimulation The Journal of Biological Chemistry. May, 2013 | Pubmed ID: 23564460 PDE4 in the Human Heart - Major Player or Little Helper? British Journal of Pharmacology. Jun, 2013 | Pubmed ID: 23489196 Parthenogenetic Stem Cells for Tissue-engineered Heart Repair The Journal of Clinical Investigation. Mar, 2013 | Pubmed ID: 23434590 [Personalized Therapy in Cardiology. Biomarkers, Pharmacogenetics and Therapy of Monogenic Diseases] Der Internist. Feb, 2013 | Pubmed ID: 23371262 A Frequent Gene Polymorphism Affecting the Heart-rate Response to Carvedilol Pharmacogenomics. Jan, 2013 | Pubmed ID: 23327570 New Tissue for Failing Hearts European Journal of Heart Failure. Jan, 2013 | Pubmed ID: 23243121 Pharmacological Characterization of 1-nitrosocyclohexyl Acetate, a Long-acting Nitroxyl Donor That Shows Vasorelaxant and Antiaggregatory Effects The Journal of Pharmacology and Experimental Therapeutics. Feb, 2013 | Pubmed ID: 23211362 A Novel Genetic Variant in the Transcription Factor Islet-1 Exerts Gain of Function on Myocyte Enhancer Factor 2C Promoter Activity European Journal of Heart Failure. Mar, 2013 | Pubmed ID: 23152444 Increased Afterload Induces Pathological Cardiac Hypertrophy: a New in Vitro Model Basic Research in Cardiology. Nov, 2012 | Pubmed ID: 23099820 The German Centre for Cardiovascular Research European Heart Journal. May, 2012 | Pubmed ID: 22893891 Progesterone Receptor Variants Associated with the PROGINS Haplotype Exhibit Functional Properties Similar to Those of Wild-type Progesterone Receptor Pharmacogenetics and Genomics. Aug, 2012 | Pubmed ID: 22722322 Increased Myocardial SERCA Expression in Early Type 2 Diabetes Mellitus is Insulin Dependent: In Vivo and in Vitro Data Cardiovascular Diabetology. May, 2012 | Pubmed ID: 22621761 Physiological Aspects of Cardiac Tissue Engineering American Journal of Physiology. Heart and Circulatory Physiology. Jul, 2012 | Pubmed ID: 22582087 Complex Interactions Between Human Myoblasts and the Surrounding 3D Fibrin-based Matrix PloS One. 2012 | Pubmed ID: 22558372 Evidence for FHL1 As a Novel Disease Gene for Isolated Hypertrophic Cardiomyopathy Human Molecular Genetics. Jul, 2012 | Pubmed ID: 22523091 Increased Myofilament Ca2+ Sensitivity and Diastolic Dysfunction As Early Consequences of Mybpc3 Mutation in Heterozygous Knock-in Mice Journal of Molecular and Cellular Cardiology. Jun, 2012 | Pubmed ID: 22465693 Localization of Islet-1-positive Cells in the Healthy and Infarcted Adult Murine Heart Circulation Research. Mar, 2012 | Pubmed ID: 22427341 Mybpc3 ターゲット マウス心肥大における欠陥の蛋白質分解システム。 Basic Research in Cardiology. Jan, 2012 | Pubmed ID: 22189562 アドレナリン作動性ストレス中隔肥大とプロテアソーム障害ノックイン ヘテロ Mybpc3 ターゲットをマウスで明らかにします。 Journal of Muscle Research and Cell Motility. Nov, 2011 | Pubmed ID: 22076249 人間中心のティッシュ基礎研究・非臨床毒性汎用ツールとして設計されて。 PloS One. 2011 | Pubmed ID: 22028871 ターミナルの分化では切片の成熟と人工心臓組織の肥大成長モデル化高度な。 Circulation Research. Oct, 2011 | Pubmed ID: 21921264 ビートに行く: 多能性幹細胞からの人間の心臓の筋肉。 Circulation Research. Jun, 2011 | Pubmed ID: 21700948 慢性収縮期心不全におけるフォリスタチンのような 1: 左心室リモデリングのマーカー。 Circulation. Heart Failure. Sep, 2011 | Pubmed ID: 21622850 間葉系幹細胞の骨芽細胞様分化人工骨様組織の機械的性質に及ぼす影響。 Tissue Engineering. Part A. Sep, 2011 | Pubmed ID: 21548844 Bisoprolol 心不全高齢患者におけるカルベジ ロール対のターゲット用量滴定: CIBIS ELD トライアル。 European Journal of Heart Failure. Jun, 2011 | Pubmed ID: 21429992 1 ホスファターゼ阻害剤-1 生理的および病態的 β-アドレナリン受容体シグナル伝達。 Cardiovascular Research. Aug, 2011 | Pubmed ID: 21354993 がん治療の心血管系副作用: 欧州心臓学会の心不全協会から位置の声明。 European Journal of Heart Failure. Jan, 2011 | Pubmed ID: 21169385 工学バイオ人工気管組織のコラーゲン ヒドロゲルのハイブリッド線維芽細胞間葉系幹細胞の培養を用いたします。 Interactive Cardiovascular and Thoracic Surgery. Feb, 2011 | Pubmed ID: 21098511 2 つの集団心の異なるマウス系統における膵島 1 陽性細胞の間の区別。 Stem Cells and Development. Jun, 2011 | Pubmed ID: 20942609 心臓肥大と萎縮性リモデリングにおける共通のマイクロ Rna 署名血行力学的負荷の変化によって誘起されます。 PloS One. 2010 | Pubmed ID: 21151612 マイクロ Rna 199b カルシニューリン/NFAT シグナル伝達を促進する自動増幅ループ内の原子核キナーゼ Dyrk1a ターゲットします。 Nature Cell Biology. Dec, 2010 | Pubmed ID: 21102440 戦いまたは飛行応答と心不全のリアノジン受容体のリン酸化鍵ですか? The Journal of Clinical Investigation. Dec, 2010 | Pubmed ID: 21099119 新しい苛性ドナー、1 Nitrosocyclohexyl 酢酸、正常および β Adrenergically 鈍感心室筋の収縮力が増加します。 Biochemical and Biophysical Research Communications. Nov, 2010 | Pubmed ID: 20946877 Myomasp/LRRC39、心と筋特異蛋白質、サルコメア M バンドの新規コンポーネントです、ストレッチ センシングに関与しています。 Circulation Research. Nov, 2010 | Pubmed ID: 20847312 ホスファターゼ 1-阻害剤 1: アンプまたはアッテネータ カテコラミン神経ストレスのですか? Basic Research in Cardiology. Sep, 2010 | Pubmed ID: 20526608 薬剤のスクリーニングのプラットフォームに基づいて開発心臓組織を設計。 Circulation Research. Jul, 2010 | Pubmed ID: 20448218 [Vernakalant: 新しい抗不整脈薬洞調律に心房細動の急速な転換のため]。 Deutsche Medizinische Wochenschrift (1946). May, 2010 | Pubmed ID: 20446233 ミエロペルオキシダーゼ心房細動 Profibrotic の仲介者として機能します。 Nature Medicine. Apr, 2010 | Pubmed ID: 20305660 恒常活性ホスファターゼ阻害剤 1 若いマウスにおける心収縮力が向上、カテコールアミン誘発性ストレス後加齢に伴う劇物です。 The Journal of Clinical Investigation. Feb, 2010 | Pubmed ID: 20071777 Atrogin 1、MuRF1 異なるメカニズムを介して心臓の MyBP C のレベルを調節します。 Cardiovascular Research. Jan, 2010 | Pubmed ID: 19850579 ユビキチン-プロテアソーム系とナンセンス変異を介した Mrna 肥大型心筋症で。 Cardiovascular Research. Jan, 2010 | Pubmed ID: 19617224 肝細胞増殖因子や血管内皮成長因子遺伝子導入は急性心筋梗塞後の間葉系幹細胞ベースの心筋サルベージを最大化 Circulation. Sep, 2009 | Pubmed ID: 19752375 MRNA の減衰とユビキチン ・ プロテアソーム システム ナンセンス変異を介した心筋マウスにおける心筋ミオシン結合蛋白質 C 変異レベルを調節します。 Circulation Research. Jul, 2009 | Pubmed ID: 19590044 人間のカルモジュリン III 遺伝子プロモーターの新しいポリモーフィズム家族性肥大型心筋症のための潜在的な修飾子遺伝子です。 European Heart Journal. Jul, 2009 | Pubmed ID: 19429631 シクラーゼを創薬のターゲットとしてキャプチャします。 Nature Reviews. Drug Discovery. Apr, 2009 | Pubmed ID: 19337273 アトルバスタチン治療は部分的にラット心臓カテコールアミンの有害な影響から保護します。 Cardiovascular Research. Apr, 2009 | Pubmed ID: 19136528 Β-アドレナリン刺激と失敗心における心筋機能。 Heart Failure Reviews. Dec, 2009 | Pubmed ID: 19110970 [Not Available] MMW Fortschritte Der Medizin. Oct, 2008 | Pubmed ID: 27372484 ラット心臓の機械的アンロード タンパク質キナーゼ ホスファターゼのバランスに大きな変化を伴います。 Journal of Molecular and Cellular Cardiology. Dec, 2008 | Pubmed ID: 18848565 人間の終末期心不全における低酸素誘導因子 (HIF) 経路の負の制御因子の活性化。 Biochemical and Biophysical Research Communications. Nov, 2008 | Pubmed ID: 18782560 アンロードされたラット心 in Vivo 心臓再分極の肥厚性表現型を表現します。 Journal of Molecular and Cellular Cardiology. Nov, 2008 | Pubmed ID: 18721926 ホスファターゼ阻害剤 1 欠損マウスはカテコールアミン誘導性不整脈と心筋肥大から保護されています。 Cardiovascular Research. Dec, 2008 | Pubmed ID: 18689792 高齢者心不全患者におけるカルベジ ロール対 Bisoprolol: 根拠と CIBIS ELD 裁判のデザイン。 Clinical Research in Cardiology : Official Journal of the German Cardiac Society. Sep, 2008 | Pubmed ID: 18542839 アンジオテンシン II およびミオシン軽鎖リン酸化ヒト心房心筋のストレッチ誘起遅いフォース応答に貢献します。 Cardiovascular Research. Sep, 2008 | Pubmed ID: 18503051 心房と心室の心筋人間の心からをストレッチする遅い力応答: 機能的関連性および細胞内メカニズム。 Progress in Biophysics and Molecular Biology. Jun-Jul, 2008 | Pubmed ID: 18466959 心に β シグナリング障害適応か死にます。 Nature Medicine. May, 2008 | Pubmed ID: 18463653 人間の心不全における ATP 結合カセットのトランスポーター。 Naunyn-Schmiedeberg's Archives of Pharmacology. May, 2008 | Pubmed ID: 18392808 アルデヒド脱水素酵素タイプ2の阻害は、ヒト静脈のニトログリセリンの血管拡張作用を減弱 FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Jul, 2008 | Pubmed ID: 18272654 甲状腺ホルモンを調節する発達タイチン アイソ フォーム遷移ホスファチジルイノシトール 3 キナーゼを介して/AKT 経路。 Circulation Research. Feb, 2008 | Pubmed ID: 18096819 灌流と健康、梗塞群ラットにおける機能評価のためのリアルタイム心筋コントラスト エコー。 Ultrasound in Medicine & Biology. Jan, 2008 | Pubmed ID: 17854980 心臓組織工学: 臨床の視点。 Future Cardiology. Jul, 2007 | Pubmed ID: 21526914 長期的な β-アドレナリン刺激は中心蛋白質ホスファターゼ阻害剤 1 のダウンレギュレーションに します。 European Journal of Heart Failure. Nov, 2007 | Pubmed ID: 17921049 心室の生物の開発支援デバイス: 小動物モデルからの予備的なデータ。 Circulation. Sep, 2007 | Pubmed ID: 17846298 心筋ミオシン結合蛋白質 C はそのまま Myocytes で完全なリラクゼーションが必要です。 Circulation Research. Oct, 2007 | Pubmed ID: 17823372 PKCalpha ターゲット アデノ ウィルス配信短いヘアピン RNA 再構成した心臓組織における収縮機能が向上します。 Journal of Molecular and Cellular Cardiology. Sep, 2007 | Pubmed ID: 17628588 人間と実験的心不全における心筋ミオシン結合蛋白質 C の減少のリン酸化のレベル。 Journal of Molecular and Cellular Cardiology. Aug, 2007 | Pubmed ID: 17560599 小動物臨床装置を用いた経胸壁心エコーの再現性 Coronary Artery Disease. Jun, 2007 | Pubmed ID: 17496492 心筋工学の萌芽期の幹細胞 Trends in Cardiovascular Medicine. May, 2007 | Pubmed ID: 17482096 心臓キャンプ合成とヌクレオシド二リン酸キナーゼ B/G タンパク質 β ガンマ ダイマー錯体による収縮の規制。 Circulation Research. Apr, 2007 | Pubmed ID: 17363702 慢性心臓カルモジュリン キナーゼ II 阻害を有するマウス α 1-アドレナリン刺激による心房収縮反応を低減しました。 Journal of Molecular and Cellular Cardiology. Mar, 2007 | Pubmed ID: 17292391 2988G 目の多形に影響を及ぼす CYP2D6 ラムダバーミニの選択的スプライシングします。 Clinical Pharmacology and Therapeutics. Nov, 2006 | Pubmed ID: 17112815 小児急性リンパ性白血病に高用量メトトレキサート: 血中濃度におよぼす ABCC2 多型の影響。 Clinical Pharmacology and Therapeutics. Nov, 2006 | Pubmed ID: 17112803 変更された Ca 2 + の分子決定の要因は、人間の慢性心房細動で処理します。 Circulation. Aug, 2006 | Pubmed ID: 16894034 最適化する心臓組織の治療への応用としてのサロゲートの心臓の筋肉設計。 Circulation. Jul, 2006 | Pubmed ID: 16820649 ミオシン軽を介したアドレナリン α 1 変力作用効果心房心筋では否定的です PKCepsilon シグナル伝達を変調します。 British Journal of Pharmacology. Aug, 2006 | Pubmed ID: 16783412 カルシニューリンとタンパク質脱燐酸化酵素 2A ホスファターゼ阻害剤 1 心筋細胞における調節におけるの役割。 Biochemical and Biophysical Research Communications. Aug, 2006 | Pubmed ID: 16774736 心臓筋肉工学: 心臓の筋肉の補充療法の更新。 Cardiovascular Research. Aug, 2006 | Pubmed ID: 16697358 人工心臓組織移植術は梗塞群ラット心における収縮および拡張機能を向上させます。 Nature Medicine. Apr, 2006 | Pubmed ID: 16582915 電気的な結合の心筋細胞シート、心臓に。 Circulation Research. Mar, 2006 | Pubmed ID: 16543504 アトルバスタチン β-アドレナリンを介して減少イソプレニル化 G γ サブユニットの心筋細胞におけるシグナル伝達先行します。 FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Apr, 2006 | Pubmed ID: 16467371 Preproenkephalin システムにおける心肥大と房室伝導におけるその役割の変化。 Cardiovascular Research. Feb, 2006 | Pubmed ID: 16376326 心筋組織のエンジニア リング。 Circulation Research. Dec, 2005 | Pubmed ID: 16339494 循環心筋再生心筋前駆細胞の妥当性を質問します。 Cardiovascular Research. Dec, 2005 | Pubmed ID: 16253213 エンドセリン 1 とイソプロテレノールの Co-stimulation による MEK 阻害の逆転部分的に収縮の失敗が発生します。 Cardiovascular Research. Dec, 2005 | Pubmed ID: 16040022 大人の心筋細胞内 5 HT4 受容体アイソ フォームの差分機能効果。 Journal of Molecular and Cellular Cardiology. Aug, 2005 | Pubmed ID: 15950987 切り捨てられた心筋ミオシン結合蛋白質 C 変異によるユビキチン-プロテアソーム系の機能障害。 Cardiovascular Research. Apr, 2005 | Pubmed ID: 15769446 ミオシン軽鎖 (MLC) キナーゼを介した MLC2a リン酸アルファ 1 アドレナリン陽性変力作用効果人間アトリウム内の重要な役割。 Cardiovascular Research. Jan, 2005 | Pubmed ID: 15621049 [心不全の β ブロッカー。いつ、どのくらい、どの物質]。 Medizinische Monatsschrift Für Pharmazeuten. Dec, 2004 | Pubmed ID: 15646690 メトプロ ロールの血漿中濃度に対するアミオダロンの効果。 The American Journal of Cardiology. Nov, 2004 | Pubmed ID: 15541258 CYP2D6 遺伝子型: 副作用と抗うつ薬パイロット研究による治療中に無応答への影響。 Clinical Pharmacology and Therapeutics. May, 2004 | Pubmed ID: 15116051 ウアバイン治療ホスファターゼ阻害剤 1 と Na のアップレギュレーションに関連付けられている C++/cli Ca(2+) 交換と β-アドレナリン感作ラット心における。 Biochemical and Biophysical Research Communications. May, 2004 | Pubmed ID: 15110776 S100A1 遺伝子導入: 心臓移植を強化するための戦略を設計します。 The Journal of Gene Medicine. Apr, 2004 | Pubmed ID: 15079813 心筋細胞の収縮機能慢性エンドセリン 1 刺激の効果。 American Journal of Physiology. Heart and Circulatory Physiology. Apr, 2004 | Pubmed ID: 15020300 N メチル-D-アスパラギン酸受容体サブユニット 2 B とリアノジン受容体 2 ラット新生児 Myocard の分子錯体の形成。 The Journal of Biological Chemistry. May, 2004 | Pubmed ID: 15010472 人間のホモの R403W 変異・心筋ミオシン不均衡な機械的および酵素の特性向上を提案する Journal of Molecular and Cellular Cardiology. Mar, 2004 | Pubmed ID: 15010274 タンパク質とリン酸化レベルは蛋白質ホスファターゼ阻害剤 - 失敗する人間の心の 1 の低下。 Cardiovascular Research. Jan, 2004 | Pubmed ID: 14732205 心臓組織の再生病気の心のために設計されました。 Biomaterials. Apr, 2004 | Pubmed ID: 14697865 ノルエピネフリン トランスフォーミング血管内皮増殖因子パラクリン機構によるラット心筋の。 Angiogenesis. 2003 | Pubmed ID: 15166499 抑制性 G タンパク質と脱感作の心不全におけるアデニル酸シクラーゼ経路におけるその役割。 Cardiovascular Research. Dec, 2003 | Pubmed ID: 14659793 大動脈弁の組織工学。 Cardiovascular Research. Dec, 2003 | Pubmed ID: 14659789 心不全の β シグナル伝達の役割は何ですか? Circulation Research. Nov, 2003 | Pubmed ID: 14615493 差動結合ひと不全心筋における M-受容 Gi/移動-蛋白質への。 Journal of Molecular and Cellular Cardiology. Oct, 2003 | Pubmed ID: 14519434 ヘム ヘムオキシゲナーゼ ‐ 1 およびその反応の製品は、一酸化炭素、マウスにおける炎症関連アポトーシス肝損傷を防ぐため。 Hepatology (Baltimore, Md.). Oct, 2003 | Pubmed ID: 14512878 Β-アドレナリン刺激心臓アンキリン リピート タンパク質の発現を誘導する: プロテインキナーゼ A およびカルモジュリン依存性キナーゼの関与。 Cardiovascular Research. Sep, 2003 | Pubmed ID: 14499857 心臓組織工学的補充療法。 Heart Failure Reviews. Jul, 2003 | Pubmed ID: 12878835 野生型 Galpha (i)-2 の過剰発現は、β-アドレナリンの心筋細胞のシグナル伝達を抑制します。 FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Mar, 2003 | Pubmed ID: 12631586 蛋白質ホスファターゼ阻害剤-1 における β-アドレナリンの心筋細胞のシグナルはアンプの役割は、再生のための証拠。 FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Mar, 2003 | Pubmed ID: 12514122 3 D 中心のティッシュの補充療法のために設計されました。 Basic Research in Cardiology. 2002 | Pubmed ID: 12479248 チトクローム P450 の頻度が増加 2 6 貧しい Metabolizers メトプロ ロール関連付けられている副作用を有する患者。 Clinical Pharmacology and Therapeutics. Oct, 2002 | Pubmed ID: 12386645 心臓移植の中心のティッシュ同系ラットのリバース エンジニア リング。 Circulation. Sep, 2002 | Pubmed ID: 12354725 減少糖蛋白受容体タンパク質 130 豊かさによって失敗する人間の心に Cardiotrophin 1 発現亢進を伴います。 Circulation. Sep, 2002 | Pubmed ID: 12234945 心臓組織工学。 Transplant Immunology. May, 2002 | Pubmed ID: 12180846 ひと心筋における 10 RGS タンパク質の発現: RGS4 のアップレギュレーション心不全における機能解析。 Cardiovascular Research. Sep, 2002 | Pubmed ID: 12176127 メトプロ ロール代謝に及ぼす CYP2D6 遺伝子型の長期治療中に永続化します。 Pharmacogenetics. Aug, 2002 | Pubmed ID: 12172215 細胞内の β 遮断: Galpha(i2) の過剰発現踏み込むそのまま心筋 β-アドレナリンの応答。 Cardiovascular Research. Aug, 2002 | Pubmed ID: 12123769 心臓アンキリン リピート蛋白質、心臓の遺伝子発現の負レギュレータは、人間の心の障害に拡張されています。 Biochemical and Biophysical Research Communications. May, 2002 | Pubmed ID: 12054667 特定のベータ (2) AR ブロック ICI 118,551 積極的に収縮を介して、G (i) を減少させる-ベータ版 (2) のフォームを結合 AR 失敗する人間の心から筋。 Circulation. May, 2002 | Pubmed ID: 12034656 心室ベータ 1-アドレナリン受容体とアルファ 1-アドレナリン受容体がないのベータ 2-のための証拠、およびマウス心臓におけるベータ 3-アドレナリン受容体機能の生理学的対立。 British Journal of Pharmacology. May, 2002 | Pubmed ID: 12010770 ラット腎血管性高血圧症におけるトラニラストによる左心室線維化の阻害です。 Journal of Hypertension. Apr, 2002 | Pubmed ID: 11910312 27 ラットの TG (mREN2) の心不全発症前に活性化左心室における心筋エンドセリン システムの肥大します。 Cardiovascular Research. Feb, 2002 | Pubmed ID: 11827687 設計された心臓組織における後負荷の磁気調整 Benjamin Becker*1,2, Marita L. Rodriguez*1,2, Tessa R. Werner1,2, Justus Stenzig1,2, Thomas Eschenhagen1,2, Marc N. Hirt1,2 1Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 2DZHK (German Centre for Cardiovascular Research) JoVE 60811 발생학 モルモット モデルにおける心筋傷害の後 - 心筋パッチのこと由来の注入 Liesa Castro1,2, Birgit Geertz3, Marina Reinsch2,3, Bülent Aksehirlioglu3, Arne Hansen2,3, Thomas Eschenhagen2,3, Hermann Reichenspurner1,2, Florian Weinberger*2,3, Simon Pecha*1,2 1Department of Cardiovascular Surgery, University Heart Center Hamburg, 2partner site Hamburg/Kiel/Lübeck, German Centre for Cardiovascular Research (DZHK), 3Department of Experimental Pharmacology and Toxicology, Cardiovascular ResearchCenter, University Medical Center Hamburg-Eppendorf JoVE 58810 의학 心臓医薬品安全性スクリーニングのための人間エンジニア心臓組織の自動収縮分析 Ingra Mannhardt1, Umber Saleem1, Anika Benzin1, Thomas Schulze1, Birgit Klampe1, Thomas Eschenhagen1, Arne Hansen1 1Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf and DZHK (German Center for Cardiovascular Research) JoVE 55461 생체공학 エンジニア心臓組織の移植後免疫反応の評価(EHT)のための生物発光イメージング Lenard Conradi1,2, Christiane Pahrmann1, Stephanie Schmidt1, Tobias Deuse1,3, Arne Hansen2, Alexandra Eder2, Hermann Reichenspurner1, Robert C. Robbins3, Thomas Eschenhagen2, Sonja Schrepfer1,3 1Transplant and Stem Cell Immunobiology Lab (TSI) and CVRC, University Hospital Hamburg, University Heart Center Hamburg, 2Department of Experimental and Clinical Pharmacology and Toxicology, University Heart Center Hamburg, 3CT Surgery, Stanford University School of Medicine JoVE 2605 생체공학
設計された心臓組織における後負荷の磁気調整 Benjamin Becker*1,2, Marita L. Rodriguez*1,2, Tessa R. Werner1,2, Justus Stenzig1,2, Thomas Eschenhagen1,2, Marc N. Hirt1,2 1Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 2DZHK (German Centre for Cardiovascular Research) JoVE 60811 발생학
モルモット モデルにおける心筋傷害の後 - 心筋パッチのこと由来の注入 Liesa Castro1,2, Birgit Geertz3, Marina Reinsch2,3, Bülent Aksehirlioglu3, Arne Hansen2,3, Thomas Eschenhagen2,3, Hermann Reichenspurner1,2, Florian Weinberger*2,3, Simon Pecha*1,2 1Department of Cardiovascular Surgery, University Heart Center Hamburg, 2partner site Hamburg/Kiel/Lübeck, German Centre for Cardiovascular Research (DZHK), 3Department of Experimental Pharmacology and Toxicology, Cardiovascular ResearchCenter, University Medical Center Hamburg-Eppendorf JoVE 58810 의학
心臓医薬品安全性スクリーニングのための人間エンジニア心臓組織の自動収縮分析 Ingra Mannhardt1, Umber Saleem1, Anika Benzin1, Thomas Schulze1, Birgit Klampe1, Thomas Eschenhagen1, Arne Hansen1 1Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf and DZHK (German Center for Cardiovascular Research) JoVE 55461 생체공학
エンジニア心臓組織の移植後免疫反応の評価(EHT)のための生物発光イメージング Lenard Conradi1,2, Christiane Pahrmann1, Stephanie Schmidt1, Tobias Deuse1,3, Arne Hansen2, Alexandra Eder2, Hermann Reichenspurner1, Robert C. Robbins3, Thomas Eschenhagen2, Sonja Schrepfer1,3 1Transplant and Stem Cell Immunobiology Lab (TSI) and CVRC, University Hospital Hamburg, University Heart Center Hamburg, 2Department of Experimental and Clinical Pharmacology and Toxicology, University Heart Center Hamburg, 3CT Surgery, Stanford University School of Medicine JoVE 2605 생체공학